Why the study?
Patients with ischemic stroke and underlying AF have a high recurrent embolic risk, but the prescription pattern of NOAC and its determinant factors in non-valvular AFAIS remained to be determined.
What are the determinant factors for NOAC prescription at discharge in patients with non-valvular AF-associated ischemic stroke?
What are the determinant factors for NOAC prescription at discharge in patients with non-valvular AF-associated ischemic stroke?
Answers are grounded in this paper and cite their sources.
In an Iranian cohort of patients with non-valvular AF-associated ischemic stroke, NOAC prescription at discharge was low (30.6%) and significantly associated with female sex, history of stroke, and stroke severity.
Background: Patients with ischemic stroke and underlying Atrial Fibrillation (AF) have a high risk of recurrent embolic events. New Oral Anticoagulant (NOAC) is highly effective and reduces the risk of recurrence in AF-associated Ischemic Stroke (AFAIS). Objectives: This study aimed to determine the prescription pattern of NOAC and its determinant factors in patients with non-valvular AFAIS. Materials & Methods: This research was a cross-sectional descriptive study and the participants were referred to an academic hospital in the north of Iran from 2017 to 2018. The study variables included demographic variables such as the use of new anticoagulants, age, sex, place of residence, income level, education, the history of stroke and myocardial Infarction (MI), medication, and stroke severity based on The National Institutes of Health Stroke Scale criteria. The patient’s functional status based on the modified Rankin Scale (mRS) was extracted from the patients’ medical records. The data analysis was conducted by SPSS V. 19, using the Chi-square test and t-test, as well as the logistic regression model. Results: In this study, 363 patients with ischemic stroke with the origin of non-valvular AF and the mean age of 67.87 years were studied. Of them, 191 (52.6%) patients were women, and 30.6% were prescribed rivaroxaban at the time of discharge. The results showed that women were more likely to use rivaroxaban than men (P=0.001, OR=0.422). The history of stroke (P=0.004, OR=2.17) and the stroke severity (P=0.05, OR=2.19) was associated with an increase in NOAC prescription. Conclusion: The results of this study showed that the administration of NOAC in this population was low and associated with gender and the severity and the history of stroke.
No takes yet. Share an insight, caveat, or question.
Moaddabi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: